MERSANA THERAPEUTICS INC (MRSN) Stock News
USA - NASDAQ:MRSN - US59045L2051 - Common Stock
8.41 USD
+0.37 (+4.6%)
MRSN Latest News, Press Relases and Analysis
All
Press Releases
2 days ago - By: Zacks Investment Research - Mentions: CRIS
4 days ago - By: Zacks Investment Research - Mentions: RPRX
2 months ago - By: Zacks Investment Research
3 months ago - By: Zacks Investment Research
3 months ago - By: Zacks Investment Research - Mentions: RNA
3 months ago - By: The Motley Fool
3 months ago - By: Benzinga
6 months ago - By: Benzinga
3 months ago - By: Mersana Therapeutics, Inc.
3 months ago - By: Zacks Investment Research - Mentions: STOK
3 months ago - By: Zacks Investment Research - Mentions: VTGN
3 months ago - By: Mersana Therapeutics, Inc.
3 months ago - By: Zacks Investment Research - Mentions: RXRX
4 months ago - By: Mersana Therapeutics, Inc.
5 months ago - By: Mersana Therapeutics, Inc.
6 months ago - By: Mersana Therapeutics, Inc.
6 months ago - By: Mersana Therapeutics, Inc.
6 months ago - By: Zacks Investment Research - Mentions: AFMD
6 months ago - By: Mersana Therapeutics, Inc.
6 months ago - By: Zacks Investment Research - Mentions: ABUS
6 months ago - By: Zacks Investment Research - Mentions: IGMS
6 months ago - By: Mersana Therapeutics, Inc.
7 months ago - By: Mersana Therapeutics, Inc.
7 months ago - By: Mersana Therapeutics, Inc.
7 months ago - By: Mersana Therapeutics, Inc.
8 months ago - By: Mersana Therapeutics, Inc.
9 months ago - By: Mersana Therapeutics, Inc.
9 months ago - By: Mersana Therapeutics, Inc.
9 months ago - By: Mersana Therapeutics, Inc.
9 months ago - By: Mersana Therapeutics, Inc.